Core Viewpoint - The company, Brain Dynamics Aurora-B (06681), has seen its stock price increase by over 5%, currently trading at 6.51 HKD with a transaction volume of 48.33 million HKD, following the announcement of its participation in a significant national technology project focused on the prevention and treatment of cognitive disorders related to intracranial atherosclerotic stenosis [1] Group 1: Project Involvement - The company’s wholly-owned subsidiary, Smart Genius Technology, is a key collaborator in the national major science and technology project titled "Research on the Prevention and Treatment of Cancer, Cardiovascular, Respiratory, and Metabolic Diseases" [1] - The project specifically addresses the challenges in diagnosing cognitive disorders caused by intracranial atherosclerotic stenosis (ICAS) and aims to establish a deep reasoning model and a comprehensive management system for early disease screening, risk assessment, and intervention tools [1] Group 2: Technological Development - As a core technology unit, the company will be responsible for the development of the deep reasoning model related to cognitive disorders caused by ICAS and the construction of a digital diagnosis and treatment platform [1] - The project has recently been officially launched, indicating a significant step forward in the company's technological capabilities and contributions to the healthcare sector [1] Group 3: Collaboration and Recognition - Smart Genius Technology, in collaboration with Xuanwu Hospital of Capital Medical University, has successfully applied for the establishment of the "Beijing Key Laboratory of Digital Medical for Cognitive Disorders," which has also been officially approved [1] - This collaboration highlights the company's commitment to advancing research and development in the field of cognitive health and its strategic partnerships with leading medical institutions [1]

Core Viewpoint - Brain动极光-B (06681) has seen a stock price increase of over 5%, currently trading at 6.51 HKD with a transaction volume of 48.33 million HKD, following the announcement of its participation in a significant national technology project focused on the treatment of cognitive disorders related to intracranial atherosclerotic stenosis [1] Group 1: Company Developments - Brain动极光's wholly-owned subsidiary, 智精灵科技, is a key collaborator in the national technology major project titled "Research on the Prevention and Treatment of Cancer, Cardiovascular, Respiratory, and Metabolic Diseases," specifically focusing on cognitive disorders related to intracranial atherosclerotic stenosis [1] - The project aims to establish key technologies for digital diagnosis and treatment of cognitive disorders, utilizing deep reasoning large models and a comprehensive management system for early disease screening, risk assessment, and intervention tools [1] - 智精灵科技 has also recently received approval for the establishment of the "Beijing Key Laboratory for Digital Medical Treatment of Cognitive Disorders," in collaboration with Capital Medical University Xuanwu Hospital [1] Group 2: Industry Context - The national technology major project addresses the clinical challenges of diagnosing and treating cognitive disorders caused by intracranial atherosclerotic stenosis (ICAS), indicating a growing focus on advanced digital health solutions in the medical field [1] - As a core technology provider, Brain动极光 is tasked with the development of deep reasoning models related to cognitive disorders and the construction of a digital diagnosis and treatment platform, highlighting the company's strategic positioning in the healthcare technology sector [1]

Core Viewpoint - Brainstorm Aurora-B (06681) has seen a stock price increase of over 5%, currently trading at 6.18 HKD with a transaction volume of 16.66 million HKD, following the announcement of its participation in a significant national technology project focused on the prevention and treatment of various diseases, including cognitive disorders related to intracranial atherosclerosis [1] Group 1: Company Developments - The company announced that its wholly-owned subsidiary, Beijing Zhijingling Technology Co., Ltd. (Zhijingling Technology), is a key partner in the national technology major project titled "Research on the Prevention and Treatment of Cancer, Cardiovascular, Respiratory, and Metabolic Diseases" [1] - The project, which has recently been officially launched, aims to address diagnostic challenges related to cognitive disorders associated with intracranial atherosclerosis (ICAS) [1] - Zhijingling Technology, in collaboration with Xuanwu Hospital of Capital Medical University, has also successfully established the "Beijing Key Laboratory of Digital Medical for Cognitive Disorders" [1] Group 2: Project Focus and Objectives - The national technology major project focuses on the diagnostic challenges of ICAS-related cognitive disorders, leveraging interdisciplinary advantages for systematic research [1] - Key objectives include the establishment of an assessment technology system for ICAS-related cognitive disorders and the development of a deep reasoning predictive model to provide early screening, risk assessment, prevention, and intervention tools [1] - The project aims to create a comprehensive management system for ICAS-related cognitive disorders, ensuring a closed-loop management approach across various scenarios [1]

Core Insights - The article discusses the evolving landscape of AI-assisted college application services, particularly in the context of high school students filling out their college applications in China. It highlights the limitations of current AI services and the potential for future advancements through deep reasoning technology. Group 1: Current State of AI College Application Services - The popularity of high-priced college application services is on the rise, with products priced at 12,999 yuan and 18,999 yuan selling out quickly [1] - Current AI college application products primarily rely on database technology, matching students' information with historical admission data to generate recommendations [2][3] - The main products in the market before 2024 are based on data filtering rather than advanced AI models [2] Group 2: Advantages of Deep Reasoning Technology - Deep reasoning technology is expected to enhance the accuracy of college application recommendations, addressing the complexities of individual student profiles [5] - The technology allows for real-time information retrieval from the internet, providing more targeted advice compared to traditional database-linked products [3] - A notable improvement in deep reasoning models has been observed, with significant advancements in performance, such as achieving a score of 145 in a national math exam [3][4] Group 3: Innovations in AI College Application Products - New algorithms utilizing graph embedding technology have been developed to analyze the relationships between different colleges and majors, improving the recommendation process [5] - The introduction of a "volunteer report" feature simulates the decision-making process of a human advisor, enhancing user experience and accuracy [6][7] - The AI college application services are becoming more accessible and affordable compared to traditional services, which can cost thousands of yuan [8] Group 4: Limitations and Future Outlook - Despite advancements, AI college application services still have shortcomings, such as occasional inaccuracies in recommendations, indicating that human advisors remain essential [9] - The collaboration between AI and human advisors is seen as complementary, with AI helping to bridge information gaps in the college application process [9] - The ongoing development of AI technology is expected to lead to a more rational and informed college application market [9]